<p>Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorisation of their Covid-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.</p>.<p>The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine.</p>.<p>In their pursuit of a European launch, potentially this year, the partners are neck-and-neck with rival Moderna, which said on Monday it would ask the EU regulator to recommend conditional approval for its shot.</p>.<p><a href="https://www.deccanherald.com/international/covid-vaccine-coronavirus-vaccine-live-updates-today-pfizer-moderna-sputnik-v-astrazeneca-oxford-bharat-biotech-covaxin-covishield-919242.html"><strong>For latest updates on coronavirus vaccine, click here</strong></a></p>.<p>U.S. drugmaker Pfizer and Germany's BioNTech reported final trial results on Nov. 18 that showed their vaccine candidate was 95% effective in preventing Covid-19, with no major safety concerns, raising the prospect of U.S. and European approval as early as December.</p>.<p>The European filing completes the so-called rolling review process, which was initiated with the EMA on Oct. 6.</p>.<p>The British government said https://www.gov.uk/government/news/government-welcomes-the-mhra-review-into-pfizer-and-biontech-vaccine last week that the US-German partners had reported the data from their clinical trials to the UK Medicines and Healthcare products Regulatory Agency (MHRA).</p>
<p>Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorisation of their Covid-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.</p>.<p>The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine.</p>.<p>In their pursuit of a European launch, potentially this year, the partners are neck-and-neck with rival Moderna, which said on Monday it would ask the EU regulator to recommend conditional approval for its shot.</p>.<p><a href="https://www.deccanherald.com/international/covid-vaccine-coronavirus-vaccine-live-updates-today-pfizer-moderna-sputnik-v-astrazeneca-oxford-bharat-biotech-covaxin-covishield-919242.html"><strong>For latest updates on coronavirus vaccine, click here</strong></a></p>.<p>U.S. drugmaker Pfizer and Germany's BioNTech reported final trial results on Nov. 18 that showed their vaccine candidate was 95% effective in preventing Covid-19, with no major safety concerns, raising the prospect of U.S. and European approval as early as December.</p>.<p>The European filing completes the so-called rolling review process, which was initiated with the EMA on Oct. 6.</p>.<p>The British government said https://www.gov.uk/government/news/government-welcomes-the-mhra-review-into-pfizer-and-biontech-vaccine last week that the US-German partners had reported the data from their clinical trials to the UK Medicines and Healthcare products Regulatory Agency (MHRA).</p>